MedKoo Cat#: 599099 | Name: Carpindolol

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Carpindolol is a beta-adrenergic blocking drug.

Chemical Structure

Carpindolol
Carpindolol
CAS#39731-05-0

Theoretical Analysis

MedKoo Cat#: 599099

Name: Carpindolol

CAS#: 39731-05-0

Chemical Formula: C19H28N2O4

Exact Mass: 348.2049

Molecular Weight: 348.44

Elemental Analysis: C, 65.49; H, 8.10; N, 8.04; O, 18.37

Price and Availability

Size Price Availability Quantity
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Carpindolol; LM 21009; LM-21009; LM21009; SDZ 21009, SDZ21009, SDZ-21009
IUPAC/Chemical Name
isopropyl 4-(3-(tert-butylamino)-2-hydroxypropoxy)-1H-indole-2-carboxylate
InChi Key
SJYFDORQYYEJLB-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H28N2O4/c1-12(2)25-18(23)16-9-14-15(21-16)7-6-8-17(14)24-11-13(22)10-20-19(3,4)5/h6-9,12-13,20-22H,10-11H2,1-5H3
SMILES Code
O=C(C(N1)=CC2=C1C=CC=C2OCC(O)CNC(C)(C)C)OC(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 348.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Hoyer D, Schoeffter P, Waeber C, Palacios JM. Serotonin 5-HT1D receptors. Ann N Y Acad Sci. 1990;600:168-81; discussion 181-2. doi: 10.1111/j.1749-6632.1990.tb16880.x. PMID: 2252308. 2: Hedo G, Lopez-Garcia JA. 5-HT(1B) but not 5-HT(6) or 5-HT(7) receptors mediate depression of spinal nociceptive reflexes in vitro. Br J Pharmacol. 2002 Feb;135(4):935-42. doi: 10.1038/sj.bjp.0704526. PMID: 11861321; PMCID: PMC1573193. 3: Frances H, Monier C, Debray M. Behavioral effect of beta-blocking drugs resulting from the stimulation or the blockade of serotonergic 5-HT1B receptors. Pharmacol Biochem Behav. 1994 Aug;48(4):965-9. doi: 10.1016/0091-3057(94)90206-2. PMID: 7972302. 4: Chojnacka-Wójcik E, Kłodzińska A. Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats. J Neural Transm Gen Sect. 1992;87(2):87-96. doi: 10.1007/BF01245010. PMID: 1348421. 5: Chojnacka-Wójcik E. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Pol J Pharmacol Pharm. 1992 Mar-Apr;44(2):135-46. PMID: 1357637. 6: Schlicker E, Fink K, Göthert M, Hoyer D, Molderings G, Roschke I, Schoeffter P. The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):45-51. doi: 10.1007/BF00169206. PMID: 2797214. 7: Molderings GJ, Werner K, Likungu J, Göthert M. Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype. Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):371-7. doi: 10.1007/BF00169451. PMID: 2255330. 8: Waeber C, Palacios JM. Non 5-HT1A/5-HT1C [3H]5-HT binding sites in the hamster, opossum, and rabbit brain show similar regional distribution but different sensitivity to beta-adrenoceptor antagonists. Synapse. 1992 Dec;12(4):261-70. doi: 10.1002/syn.890120403. PMID: 1361246. 9: Mitsikostas DD, Sanchez del Rio M, Moskowitz MA, Waeber C. Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis. Eur J Pharmacol. 1999 Mar 26;369(3):271-7. doi: 10.1016/s0014-2999(99)00067-9. PMID: 10225363. 10: Chojnacka-Wójcik E, Przegaliński E. Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats. Neuropharmacology. 1991 Jul;30(7):703-9. doi: 10.1016/0028-3908(91)90177-d. PMID: 1681448. 11: Ishizuka J, Beauchamp RD, Townsend CM Jr, Greeley GH Jr, Thompson JC. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol. 1992 Jan;150(1):1-7. doi: 10.1002/jcp.1041500102. PMID: 1309821. 12: Cattaneo MG, Palazzi E, Bondiolotti G, Vicentini LM. 5-HT1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma. Eur J Pharmacol. 1994 Aug 16;268(3):425-30. doi: 10.1016/0922-4106(94)90068-x. PMID: 7805767. 13: Berthold H, Fozard JR, Engel G. 5-HT1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice. Eur J Pharmacol. 1989 Mar 14;162(1):19-27. doi: 10.1016/0014-2999(89)90599-2. PMID: 2566495. 14: Schoeffter P, Hoyer D. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta- adrenoceptor antagonists. Naunyn Schmiedebergs Arch Pharmacol. 1989 Sep;340(3):285-92. doi: 10.1007/BF00168512. PMID: 2572975. 15: Waeber C, Dietl MM, Hoyer D, Palacios JM. 5.HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):486-94. doi: 10.1007/BF00260602. PMID: 2533325. 16: Waeber C, Schoeffter P, Palacios JM, Hoyer D. 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies. Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):479-85. doi: 10.1007/BF00260601. PMID: 2533324. 17: Waeber C, Palacios JM. 5-HT1 receptor binding sites in the guinea pig superior colliculus are predominantly of the 5-HT1D class and are presynaptically located on primary retinal afferents. Brain Res. 1990 Oct 1;528(2):207-11. doi: 10.1016/0006-8993(90)91659-5. PMID: 2271922.